Tapewire

Nasdaq · USD

AMLX

Amylyx Pharmaceuticals, Inc.

Export transactions ↓
Tapewire entity
259
SEC CIK
0001658551
Parsed reports
204

Last 12 months

Inside the activity.

2 purchase rows · 31 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202511
Jan 202607
Feb 202605
Mar 202605
Apr 202600
May 202610
Jun 202600
Jul 202602
Aug 202600
Sep 2026010
Oct 202601

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 16, 2026 Filed Jan 21, 2026 02:46 UTC
Klee Justin B.Director · Co-Chief Executive Officer
Exercise / conversionCommon Stock 2,847 $7.57 $21,551.79
Disclosure

SEC source: 0001193125-26-017056 · ownership.xml · nonDerivative · entry 3

Klee Justin B. · CIK 0001898314 · Director · Co-Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,381,393

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 16, 2026 Filed Jan 21, 2026 02:46 UTC
Cohen Joshua BDirector · Co-Chief Executive Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 2,818 $0.00 Strike: $7.57 $0.00
Disclosure

SEC source: 0001193125-26-017057 · ownership.xml · derivative · entry 6

Cohen Joshua B · CIK 0001898644 · Director · Co-Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,818 shares

Expires 2026-02-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: This option is fully vested and exercisable. The option is due to expire on February 19, 2026.

Read SEC document
January 16, 2026 Filed Jan 21, 2026 02:46 UTC
Cohen Joshua BDirector · Co-Chief Executive Officer
SaleCommon Stock 1,974 $13.83 $27,299.04
Disclosure

SEC source: 0001193125-26-017057 · ownership.xml · nonDerivative · entry 4

Cohen Joshua B · CIK 0001898644 · Director · Co-Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,379,465

F1 · kind: Reflects shares sold to cover option cost and tax obligations upon the option exercise pursuant to a preset sales plan adopted by the reporting person on November 12, 2025.

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $13.82 to $13.835. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
January 16, 2026 Filed Jan 21, 2026 02:46 UTC
Cohen Joshua BDirector · Co-Chief Executive Officer
Exercise / conversionCommon Stock 2,818 $7.57 $21,332.26
Disclosure

SEC source: 0001193125-26-017057 · ownership.xml · nonDerivative · entry 3

Cohen Joshua B · CIK 0001898644 · Director · Co-Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,381,439

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 15, 2026 Filed Jan 21, 2026 02:46 UTC
Klee Justin B.Director · Co-Chief Executive Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 197,153 $0.00 Strike: $7.57 $0.00
Disclosure

SEC source: 0001193125-26-017056 · ownership.xml · derivative · entry 5

Klee Justin B. · CIK 0001898314 · Director · Co-Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,847

Underlying: Common Stock · 197,153 shares

Expires 2026-02-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: This option is fully vested and exercisable. The option is due to expire on February 19, 2026.

Read SEC document
January 15, 2026 Filed Jan 21, 2026 02:46 UTC
Klee Justin B.Director · Co-Chief Executive Officer
SaleCommon Stock 136,193 $13.58 $1,849,868.66
Disclosure

SEC source: 0001193125-26-017056 · ownership.xml · nonDerivative · entry 2

Klee Justin B. · CIK 0001898314 · Director · Co-Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,378,546

F1 · kind: Reflects shares sold to cover option cost and tax obligations upon the option exercise pursuant to a preset sales plan adopted by the reporting person on November 12, 2025.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $13.26 to $13.77. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
January 15, 2026 Filed Jan 21, 2026 02:46 UTC
Klee Justin B.Director · Co-Chief Executive Officer
Exercise / conversionCommon Stock 197,153 $7.57 $1,492,448.21
Disclosure

SEC source: 0001193125-26-017056 · ownership.xml · nonDerivative · entry 1

Klee Justin B. · CIK 0001898314 · Director · Co-Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,514,739

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 15, 2026 Filed Jan 21, 2026 02:46 UTC
Cohen Joshua BDirector · Co-Chief Executive Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 197,182 $0.00 Strike: $7.57 $0.00
Disclosure

SEC source: 0001193125-26-017057 · ownership.xml · derivative · entry 5

Cohen Joshua B · CIK 0001898644 · Director · Co-Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,818

Underlying: Common Stock · 197,182 shares

Expires 2026-02-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: This option is fully vested and exercisable. The option is due to expire on February 19, 2026.

Read SEC document
January 15, 2026 Filed Jan 21, 2026 02:46 UTC
Cohen Joshua BDirector · Co-Chief Executive Officer
SaleCommon Stock 136,193 $13.59 $1,850,794.77
Disclosure

SEC source: 0001193125-26-017057 · ownership.xml · nonDerivative · entry 2

Cohen Joshua B · CIK 0001898644 · Director · Co-Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,378,621

F1 · kind: Reflects shares sold to cover option cost and tax obligations upon the option exercise pursuant to a preset sales plan adopted by the reporting person on November 12, 2025.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $13.26 to $13.76. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
January 15, 2026 Filed Jan 21, 2026 02:46 UTC
Cohen Joshua BDirector · Co-Chief Executive Officer
Exercise / conversionCommon Stock 197,182 $7.57 $1,492,667.74
Disclosure

SEC source: 0001193125-26-017057 · ownership.xml · nonDerivative · entry 1

Cohen Joshua B · CIK 0001898644 · Director · Co-Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,514,814

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 12, 2026 Filed Jan 14, 2026 21:08 UTC GiftCommon Stock 17,780 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-012921 · ownership.xml · nonDerivative · entry 1

MILNE GEORGE M JR · CIK 0001179552 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 812,881

F1 · kind: Represents a bona fide gift for no consideration.

Read SEC document
January 06, 2026 Filed Jan 8, 2026 21:05 UTC
Cohen Joshua BDirector · Co-Chief Executive Officer
SaleCommon Stock 7,715 $11.09 $85,596.38
Disclosure

SEC source: 0001193125-26-007666 · ownership.xml · nonDerivative · entry 1

Cohen Joshua B · CIK 0001898644 · Director · Co-Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,317,632

F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F1 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $11.05 to $11.14. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
January 06, 2026 Filed Jan 8, 2026 21:05 UTC
Klee Justin B.Director · Co-Chief Executive Officer
SaleCommon Stock 7,715 $11.09 $85,589.44
Disclosure

SEC source: 0001193125-26-007664 · ownership.xml · nonDerivative · entry 1

Klee Justin B. · CIK 0001898314 · Director · Co-Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,317,586

F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F1 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $10.99 to $11.16. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
January 06, 2026 Filed Jan 8, 2026 21:05 UTC
FRATES JAMES MChief Financial Officer
SaleCommon Stock 3,326 $11.11 $36,953.86
Disclosure

SEC source: 0001193125-26-007669 · ownership.xml · nonDerivative · entry 1

FRATES JAMES M · CIK 0001235598 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 177,104

F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F1 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $10.99 to $11.16. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
December 23, 2025 Filed Dec 24, 2025 01:48 UTC PurchaseCommon Stock 8,100 $12.45 $100,845.00
Disclosure

SEC source: 0001193125-25-331289 · ownership.xml · nonDerivative · entry 1

Firestone Karen · CIK 0001969821 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,100

Read SEC document
December 01, 2025 Filed Dec 3, 2025 21:39 UTC
Bedrosian Camille LChief Medical Officer
SaleCommon Stock 6,580 $14.35 $94,418.39
Disclosure

SEC source: 0001193125-25-306818 · ownership.xml · nonDerivative · entry 1

Bedrosian Camille L · CIK 0001326969 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 175,756

F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F1 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.30 to $14.42. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
September 30, 2025 Filed Oct 2, 2025 20:15 UTC
Cohen Joshua BDirector · Co-Chief Executive Officer
SaleCommon Stock 200 $15.00 $2,999.50
Disclosure

SEC source: 0001193125-25-228340 · ownership.xml · nonDerivative · entry 2

Cohen Joshua B · CIK 0001898644 · Director · Co-Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,325,347

F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F1 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.995 to $15.00. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
September 30, 2025 Filed Oct 2, 2025 20:15 UTC
Cohen Joshua BDirector · Co-Chief Executive Officer
SaleCommon Stock 29,733 $14.34 $426,469.34
Disclosure

SEC source: 0001193125-25-228340 · ownership.xml · nonDerivative · entry 1

Cohen Joshua B · CIK 0001898644 · Director · Co-Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,325,547

F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F1 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $13.99 to $14.95. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
September 30, 2025 Filed Oct 2, 2025 20:15 UTC
Klee Justin B.Director · Co-Chief Executive Officer
SaleCommon Stock 200 $15.01 $3,002.00
Disclosure

SEC source: 0001193125-25-228343 · ownership.xml · nonDerivative · entry 2

Klee Justin B. · CIK 0001898314 · Director · Co-Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,325,301

F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F1 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $15.00 to $15.02. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
September 30, 2025 Filed Oct 2, 2025 20:15 UTC
Klee Justin B.Director · Co-Chief Executive Officer
SaleCommon Stock 29,775 $14.37 $427,950.12
Disclosure

SEC source: 0001193125-25-228343 · ownership.xml · nonDerivative · entry 1

Klee Justin B. · CIK 0001898314 · Director · Co-Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,325,501

F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F1 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $13.99 to $14.98. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
September 30, 2025 Filed Oct 2, 2025 20:15 UTC
Mazzariello GinaChief Legal Officer
SaleCommon Stock 8,828 $14.58 $128,668.98
Disclosure

SEC source: 0001193125-25-228342 · ownership.xml · nonDerivative · entry 1

Mazzariello Gina · CIK 0001913765 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 148,141

F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F1 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.355 to $15.075. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
September 30, 2025 Filed Oct 2, 2025 20:15 UTC
FRATES JAMES MChief Financial Officer
SaleCommon Stock 10,558 $14.65 $154,650.42
Disclosure

SEC source: 0001193125-25-228341 · ownership.xml · nonDerivative · entry 1

FRATES JAMES M · CIK 0001235598 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 280,430

F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F1 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.35 to $15.075. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
September 30, 2025 Filed Oct 2, 2025 20:15 UTC
Bedrosian Camille LChief Medical Officer
SaleCommon Stock 12,039 $14.58 $175,517.78
Disclosure

SEC source: 0001193125-25-228339 · ownership.xml · nonDerivative · entry 1

Bedrosian Camille L · CIK 0001326969 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 182,336

F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F1 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.35 to $15.04. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
August 13, 2025 Filed Aug 14, 2025 20:20 UTC
Mazzariello GinaChief Legal Officer
SaleCommon Stock 15,000 $8.34 $125,046.00
Disclosure

SEC source: 0000950170-25-108912 · ownership.xml · nonDerivative · entry 2

Mazzariello Gina · CIK 0001913765 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 156,969

F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on May 13, 2025.

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.13 to $8.47. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
August 12, 2025 Filed Aug 14, 2025 20:20 UTC
Mazzariello GinaChief Legal Officer
SaleCommon Stock 15,000 $8.07 $121,102.50
Disclosure

SEC source: 0000950170-25-108912 · ownership.xml · nonDerivative · entry 1

Mazzariello Gina · CIK 0001913765 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 171,969

F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on May 13, 2025.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $7.82 to $8.27. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
June 05, 2025 Filed Jun 9, 2025 20:06 UTC GrantStock Option (right to buy) · Derivative 25,000 $0.00 Strike: $5.05 $0.00
Disclosure

SEC source: 0000950170-25-083713 · ownership.xml · derivative · entry 1

MILNE GEORGE M JR · CIK 0001179552 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2035-06-04

F1 · derivative.exercise_date: The shares subject to this option shall vest in full upon the earlier of (i) June 5, 2026 or (ii) the date of the next annual meeting, subject to the Reporting Person's continuous service to the Issuer through such vesting date.

Read SEC document
June 05, 2025 Filed Jun 9, 2025 16:06 UTC GrantStock Option (right to buy) · Derivative 25,000 $0.00 Strike: $5.05 $0.00
Disclosure

SEC source: 0000950170-25-083709 · ownership.xml · derivative · entry 1

Zeiher Bernhardt G · CIK 0001971421 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2035-06-04

F1 · derivative.exercise_date: The shares subject to this option shall vest in full upon the earlier of (i) June 5, 2026 or (ii) the date of the next annual meeting, subject to the Reporting Person's continuous service to the Issuer through such vesting date.

Read SEC document
June 05, 2025 Filed Jun 9, 2025 20:12 UTC GrantStock Option (right to buy) · Derivative 25,000 $0.00 Strike: $5.05 $0.00
Disclosure

SEC source: 0000950170-25-083734 · ownership.xml · derivative · entry 1

FONTEYNE PAUL R. · CIK 0001727550 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2035-06-04

F1 · derivative.exercise_date: The shares subject to this option shall vest in full upon the earlier of (i) June 5, 2026 or (ii) the date of the next annual meeting, subject to the Reporting Person's continuous service to the Issuer through such vesting date.

Read SEC document
June 05, 2025 Filed Jun 9, 2025 20:08 UTC GrantStock Option (right to buy) · Derivative 25,000 $0.00 Strike: $5.05 $0.00
Disclosure

SEC source: 0000950170-25-083719 · ownership.xml · derivative · entry 1

Firestone Karen · CIK 0001969821 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2035-06-04

F1 · derivative.exercise_date: The shares subject to this option shall vest in full upon the earlier of (i) June 5, 2026 or (ii) the date of the next annual meeting, subject to the Reporting Person's continuous service to the Issuer through such vesting date.

Read SEC document
June 05, 2025 Filed Jun 9, 2025 20:07 UTC
Quimi DaphneDirector
GrantStock Option (right to buy) · Derivative 25,000 $0.00 Strike: $5.05 $0.00
Disclosure

SEC source: 0000950170-25-083717 · ownership.xml · derivative · entry 1

Quimi Daphne · CIK 0001543031 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2035-06-04

F1 · derivative.exercise_date: The shares subject to this option shall vest in full upon the earlier of (i) June 5, 2026 or (ii) the date of the next annual meeting, subject to the Reporting Person's continuous service to the Issuer through such vesting date.

Read SEC document
May 22, 2025 Filed May 27, 2025 20:01 UTC
Mazzariello GinaChief Legal Officer
GiftCommon Stock 1,000 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-077677 · ownership.xml · nonDerivative · entry 1

Mazzariello Gina · CIK 0001913765 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 186,969

F1 · kind: Represents a bona fide gift for no consideration.

F1 · shares: Represents a bona fide gift for no consideration.

Read SEC document
March 31, 2025 Filed Apr 2, 2025 20:57 UTC
Cohen Joshua BDirector · Co-Chief Executive Officer
SaleCommon Stock 21,490 $3.47 $74,482.19
Disclosure

SEC source: 0000950170-25-049513 · ownership.xml · nonDerivative · entry 1

Cohen Joshua B · CIK 0001898644 · Director · Co-Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,355,280

F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F1 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.435 to $3.58. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
March 31, 2025 Filed Apr 2, 2025 20:52 UTC
Klee Justin B.Director · Co-Chief Executive Officer
SaleCommon Stock 21,490 $3.46 $74,454.25
Disclosure

SEC source: 0000950170-25-049495 · ownership.xml · nonDerivative · entry 1

Klee Justin B. · CIK 0001898314 · Director · Co-Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,355,276

F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F1 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.44 to $3.58. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
March 31, 2025 Filed Apr 2, 2025 21:22 UTC
FRATES JAMES MChief Financial Officer
SaleCommon Stock 10,896 $3.47 $37,805.85
Disclosure

SEC source: 0000950170-25-049581 · ownership.xml · nonDerivative · entry 1

FRATES JAMES M · CIK 0001235598 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 290,988

F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F1 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.44 to $3.58. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
March 31, 2025 Filed Apr 2, 2025 21:14 UTC
Bedrosian Camille LChief Medical Officer
SaleCommon Stock 12,425 $3.47 $43,082.45
Disclosure

SEC source: 0000950170-25-049567 · ownership.xml · nonDerivative · entry 1

Bedrosian Camille L · CIK 0001326969 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 194,375

F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F1 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.44 to $3.58. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
March 31, 2025 Filed Apr 2, 2025 21:12 UTC
Mazzariello GinaChief Legal Officer
SaleCommon Stock 9,192 $3.48 $31,954.15
Disclosure

SEC source: 0000950170-25-049560 · ownership.xml · nonDerivative · entry 1

Mazzariello Gina · CIK 0001913765 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 187,969

F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F1 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.44 to $3.58. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
March 20, 2025 Filed Mar 24, 2025 16:15 UTC PurchaseCommon Stock 10,000 $3.70 $37,005.00
Disclosure

SEC source: 0000950170-25-043849 · ownership.xml · nonDerivative · entry 1

Zeiher Bernhardt G · CIK 0001971421 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

F1 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.65 to $3.73. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request.

Read SEC document
March 06, 2025 Filed Mar 11, 2025 00:28 UTC
Cohen Joshua BDirector · Co-Chief Executive Officer
GrantStock Option (Right to Buy) · Derivative 270,177 $0.00 Strike: $3.61 $0.00
Disclosure

SEC source: 0000950170-25-036708 · ownership.xml · derivative · entry 2

Cohen Joshua B · CIK 0001898644 · Director · Co-Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 270,177

Underlying: Common Stock · 270,177 shares

Expires 2035-03-05

F2 · derivative.exercise_date: 25% of the shares subject to the option shall vest and become exercisable on March 1, 2026, and the remaining shares shall vest monthly over the remaining 36 months, subject to the Reporting Person's continuous service to the Issuer through each such vesting date.

Read SEC document
March 06, 2025 Filed Mar 11, 2025 00:28 UTC
Cohen Joshua BDirector · Co-Chief Executive Officer
GrantCommon Stock 180,118 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-036708 · ownership.xml · nonDerivative · entry 1

Cohen Joshua B · CIK 0001898644 · Director · Co-Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,376,770

F1 · shares: The reported transaction involves the Reporting Person's receipt of a restricted stock unit ("RSU") award. The RSUs shall vest in 4 equal annual installments, with the first installment vesting on March 1, 2026, subject to the Reporting Person's continued service to the Issuer through each such vesting date.

Read SEC document
March 06, 2025 Filed Mar 11, 2025 00:30 UTC
Klee Justin B.Director · Co-Chief Executive Officer
GrantStock Option (right to buy) · Derivative 270,177 $0.00 Strike: $3.61 $0.00
Disclosure

SEC source: 0000950170-25-036711 · ownership.xml · derivative · entry 2

Klee Justin B. · CIK 0001898314 · Director · Co-Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 270,177

Underlying: Common Stock · 270,177 shares

Expires 2035-03-05

F2 · derivative.exercise_date: 25% of the shares subject to the option shall vest and become exercisable on March 1, 2026, and the remaining shares shall vest monthly over the remaining 36 months, subject to the Reporting Person's continuous service to the Issuer through each such vesting date.

Read SEC document
March 06, 2025 Filed Mar 11, 2025 00:30 UTC
Klee Justin B.Director · Co-Chief Executive Officer
GrantCommon Stock 180,118 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-036711 · ownership.xml · nonDerivative · entry 1

Klee Justin B. · CIK 0001898314 · Director · Co-Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,376,766

F1 · shares: The reported transaction involves the Reporting Person's receipt of a restricted stock unit ("RSU") award. The RSUs shall vest in 4 equal annual installments, with the first installment vesting on March 1, 2026, subject to the Reporting Person's continued service to the Issuer through each such vesting date.

Read SEC document
March 06, 2025 Filed Mar 11, 2025 00:34 UTC
Mazzariello GinaChief Legal Officer
GrantStock Option (right to buy) · Derivative 95,777 $0.00 Strike: $3.61 $0.00
Disclosure

SEC source: 0000950170-25-036717 · ownership.xml · derivative · entry 2

Mazzariello Gina · CIK 0001913765 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 95,777

Underlying: Common Stock · 95,777 shares

Expires 2035-03-05

F2 · derivative.exercise_date: 25% of the shares subject to the option shall vest and become exercisable on March 1, 2026, and the remaining shares shall vest monthly over the remaining 36 months, subject to the Reporting Person's continuous service to the Issuer through each such vesting date.

Read SEC document
March 06, 2025 Filed Mar 11, 2025 00:34 UTC
Mazzariello GinaChief Legal Officer
GrantCommon Stock 63,851 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-036717 · ownership.xml · nonDerivative · entry 1

Mazzariello Gina · CIK 0001913765 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 197,161

F1 · shares: The reported transaction involves the Reporting Person's receipt of a restricted stock unit ("RSU") award. The RSUs shall vest in 4 equal annual installments, with the first installment vesting on March 1, 2026, subject to the Reporting Person's continued service to the Issuer through each such vesting date.

Read SEC document
March 06, 2025 Filed Mar 11, 2025 00:28 UTC
FRATES JAMES MChief Financial Officer
GrantStock Option (right to buy) · Derivative 102,630 $0.00 Strike: $3.61 $0.00
Disclosure

SEC source: 0000950170-25-036707 · ownership.xml · derivative · entry 4

FRATES JAMES M · CIK 0001235598 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 102,630

Underlying: Common Stock · 102,630 shares

Expires 2035-03-05

F4 · derivative.exercise_date: 25% of the shares subject to the option shall vest and become exercisable on March 1, 2026, and the remaining shares shall vest monthly over the remaining 36 months, subject to the Reporting Person's continuous service to the Issuer through each such vesting date.

Read SEC document
March 06, 2025 Filed Mar 11, 2025 00:28 UTC
FRATES JAMES MChief Financial Officer
GrantCommon Stock 68,420 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-036707 · ownership.xml · nonDerivative · entry 1

FRATES JAMES M · CIK 0001235598 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 301,884

F1 · shares: The reported transaction involves the Reporting Person's receipt of a restricted stock unit ("RSU") award. The RSUs shall vest in 4 equal annual installments, with the first installment vesting on March 1, 2026, subject to the Reporting Person's continued service to the Issuer through each such vesting date.

Read SEC document
March 06, 2025 Filed Mar 11, 2025 00:32 UTC
Bedrosian Camille LChief Medical Officer
GrantStock Option (Right to Buy) · Derivative 102,630 $0.00 Strike: $3.61 $0.00
Disclosure

SEC source: 0000950170-25-036712 · ownership.xml · derivative · entry 2

Bedrosian Camille L · CIK 0001326969 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 102,630

Underlying: Common Stock · 102,630 shares

Expires 2035-03-05

F2 · derivative.exercise_date: 25% of the shares subject to the option shall vest and become exercisable on March 1, 2026, and the remaining shares shall vest monthly over the remaining 36 months, subject to the Reporting Person's continuous service to the Issuer through each such vesting date.

Read SEC document
March 06, 2025 Filed Mar 11, 2025 00:32 UTC
Bedrosian Camille LChief Medical Officer
GrantCommon Stock 68,420 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-036712 · ownership.xml · nonDerivative · entry 1

Bedrosian Camille L · CIK 0001326969 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 206,800

F1 · shares: The reported transaction involves the Reporting Person's receipt of a restricted stock unit ("RSU") award. The RSUs shall vest in 4 equal annual installments, with the first installment vesting on March 1, 2026, subject to the Reporting Person's continued service to the Issuer through each such vesting date.

Read SEC document
March 03, 2025 Filed Mar 5, 2025 21:32 UTC
Cohen Joshua BDirector · Co-Chief Executive Officer
SaleCommon Stock 4,595 $3.17 $14,549.15
Disclosure

SEC source: 0000950170-25-033719 · ownership.xml · nonDerivative · entry 1

Cohen Joshua B · CIK 0001898644 · Director · Co-Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,196,652

F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F1 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.09 to $3.195. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
March 03, 2025 Filed Mar 5, 2025 21:35 UTC
Klee Justin B.Director · Co-Chief Executive Officer
SaleCommon Stock 4,595 $3.15 $14,483.44
Disclosure

SEC source: 0000950170-25-033725 · ownership.xml · nonDerivative · entry 1

Klee Justin B. · CIK 0001898314 · Director · Co-Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,196,648

F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F1 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.10 to $3.19. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
March 03, 2025 Filed Mar 5, 2025 21:32 UTC
Mazzariello GinaChief Legal Officer
SaleCommon Stock 1,611 $3.12 $5,022.29
Disclosure

SEC source: 0000950170-25-033717 · ownership.xml · nonDerivative · entry 1

Mazzariello Gina · CIK 0001913765 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 133,310

F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F1 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.10 to $3.165. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.